Genmab A/S's total assets for Q1 2025 were kr6.59B, a decrease of -85.62% from the previous quarter. GB:0MGB total liabilities were kr1.29B for the fiscal quarter, a -85.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.